Care&D
ActiveCare&D has been active since 2017 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €64k and a net result of €18k. Equity is shrinking by ~3.6% per year across the filed fiscal years. Its solvency ranks better than 56% of 211 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.4% (very low).
Checked score
Score 2025
76
/ 100
Excellent
The score weighs solvency, liquidity and profitability. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability77▲+60
Solvency82▲+6
Growth52▲+20
Track record100
Bankruptcy probability, 12 months
0.4%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €4.5k at 30 days acceptable
Liquidity ample (current ratio 2.35 against 2.05 in 2024; short-term debt: 42.6% and cash: 20.9% of total assets), and 42.6% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Seven signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 72
Relative position
BE, all sectors
reference
Sector 72
lower
← fewer bankruptcies
more bankruptcies →
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
57.4%
Return on assets
16%
Age of the figures
9 mo
lowers risk · Growing equity
Reported equity is higher than in 2023 and did not fall compared with 2024. These amounts do not establish the cause of the change.
NBB · annual accounts 2025Equity per financial year
1819202122232425
2018 to 2025 · latest year €64k
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 13-07-2026, 18 days ahead of the deadline.
NBB · 8 filingsDeviation from the deadline
2025
18 d early
2024
48 d early
2023
14 d early
2022
47 d early
2021
30 d early
2020
18 d late
2019
14 d early
← before the deadline
after the deadline →
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
16-09-2026 today31-12-2026 close31-07-2027 deadline
Financials · fiscal year 2025, abbreviated schema
Turnover
Not included in this filing
EBIT margin
Not included in this filing
Net result
€18k
2024 · €-7k
2018: €44k
2019: €-601
2020: €14k
2021: €-11k
2022: €-12k
2023: €384
2024: €-7k
2018 → 2025
Working capital
€64k▲ 38.6%
2024 · €46k
2018: €63k
2019: €62k
2020: €77k
2021: €66k
2022: €53k
2023: €54k
2024: €46k
2018 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20212022202320242025Trend
Equity€66k-€53k▼ 18.6%€54k▲ 0.7%€46k▼ 13.7%€64k▲ 38.6%
Operating result€-11k-€-12k▼ 12.1%€495€-7k€18k
Net result€-11k-€-12k▼ 11.8%€384€-7k€18k
Result per fiscal year
Operating resultNet result
The operating result returns to profit in 2025: €18k after a loss of €7k in 2024, the highest result in the available series.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Equity and liabilities €112k
Equity
€64k▲ 38.6%
Debt
€48k▲ 8.4%
The debt ratio falls from 48.7% to 42.6%. Equity and debt are higher.
Key figures and ratios
Solvency
57.4%▲
2024 · 51.3%
Current ratio
2.35▲
2024 · 2.05
Quick ratio
2.35▲
2024 · 2.05
Debt / equity
0.74▼
2024 · 0.95
ROE
27.8%▲
2024 · -16.1%
ROA
16.0%▲
2024 · -8.3%
Debt
€48k▲
2024 · €44k
Debt ≤ 1 year
€48k▲
2024 · €44k
Staff costs
€181k▲
2024 · €149k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2025 against 2024
Balance sheet
Code20242025
Assets
Total assets20/58€91k€112k▲
Current assets29/58€91k€112k▲
Amounts receivable within one year40/41€64k€77k▲
Trade receivables40€64k€77k▲
Other amounts receivable41€110€0▼
Cash at bank and in hand54/58€24k€23k▼
Deferred charges and accrued income490/1€2k€12k▲
Equity and liabilities
Total equity and liabilities10/49€91k€112k▲
Equity10/15€46k€64k▲
Contributions10/11€19k€19k=
Reserves13€2k€2k=
Distributable reserves133€2k€2k=
Profit (loss) carried forward14€26k€44k▲
Amounts payable17/49€44k€48k▲
Amounts payable within one year42/48€44k€48k▲
Trade debts44€10k€12k▲
Suppliers440/4€10k€12k▲
Taxes, remuneration and social security45€34k€35k▲
Taxes450/3€10k€11k▲
Remuneration and social security454/9€25k€25k▲
Income statement
Code20242025
Remuneration, social security and pensions62€149k€181k▲
Write-downs on stocks, contracts in progress and trade receivables: additions (reversals)631/4-€10k
Other operating charges640/8€10k€0▼
Non-recurring operating charges66A-€23
Gross operating margin9900€151k€209k▲
Operating profit (loss)9901€-7k€18k▲
Financial income75/76B€9€0▼
Recurring financial income75€9€0▼
Financial charges65/66B€138€353▲
Recurring financial charges65€138€353▲
Profit (loss) for the period before taxes9903€-7k€18k▲
Profit (loss) for the period9904€-7k€18k▲
Profit (loss) for the period to be appropriated9905€-7k€18k▲
Appropriation of the result
Profit (loss) to be appropriated9906€26k€44k▲
Profit (loss) brought forward from the previous period14P€34k€26k▼
Social balance
Average headcount (FTE)90872.42.7▲
The notes to these accounts (3 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
13-07
NBB filing
Annual accounts filed
fiscal year 2025 · abbreviated schema
2025
31-12
Financial
Back to profitnet €18k
Net result €18k after one loss-making year.
13-06
NBB filing
Annual accounts filed
fiscal year 2024 · full schema
2024
17-07
NBB filing
Annual accounts filed
fiscal year 2023 · full schema
2023
31-12
Financial
Back to profitnet €384
Net result €384 after 2 loss-making years.
14-06
NBB filing
Annual accounts filed
fiscal year 2022 · full schema
2022
31-12
Financial
Weakest financial yearnet €-12k
Net result drops to €-12k, the lowest in the series; recovery starts the following year.
01-07
NBB filing
Annual accounts filed
fiscal year 2021 · full schema
2021
18-08
NBB filing
Annual accounts filed
fiscal year 2020 · full schema · 18 days late
2020
31-12
Financial
Back to profitnet €14k
Net result €14k after one loss-making year.
17-07
NBB filing
Annual accounts filed
fiscal year 2019 · micro schema
2019
09-08
NBB filing
Annual accounts filed
fiscal year 2018 · micro schema · 9 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
3 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Bertrix · 1 establishment unit since 2017
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Rue de Lonnoux 26880 BertrixGround area
3.4 ha
Building footprint
3,504 m²
Volume, LiDAR
31,891 m³
Parcel 84009C0848/00H005, Wallonia · tallest building 12.0 m, ±3 floors. Linked by address, not a title deed.
1 establishment unit
CONPALUX RECHERCHE & DEVELOPPEMENT
since 20172.265.711.251
1 parcel
Wallonia
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 84009C0848/00H005 | Wallonia | 3.4 ha | 1 · 3,504 m² | 12.0 m · 3 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector, comparable size
HU-MENTIS
BE 0743.421.064
Walcourt · Eq €64k
Dr. Frank Chielens Algemene Geneeskunde
BE 0444.485.078
Ieper · Eq €64k
IndusFilter
BE 0698.642.894
Gent · Eq €64k
NuStats Lab
BE 1010.533.033
Erpe-Mere · Eq €63k
DOCTEUR PAOLO BATTISTI
BE 1011.794.726
Clavier · Eq €65k
Of 760 companies in sector 72101 we hold annual accounts for 481. 262 are within a factor 10 of this equity.See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded09-06-2017
Fiscal year end31-12
Activities, NACEBEL
72101Research and development on biotechnology
74909Other professional, scientific and technical activities
74999Other professional, scientific and technical activities
Sources
Crossroads Bank for EnterprisesNational Bank · 8 filingsAddress and cadastre registers
Data from official sources, last processed on 16-09-2026. Scores and ratios are computed by Checked and are not a credit decision.